The Role of p16, p21, p27, p53 and Ki-67 Expression in the Differential Diagnosis of Cutaneous Squamous Cell Carcinomas and Keratoacanthomas: An Immunohistochemical Study
Results: The results of all of the examined markers, except for p27 (p16, p21, p53, and Ki-67) were found to be significantly different between the SCC and KA samples (p
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Background: Distinguishing squamous cell carcinoma (SCC) from keratoacanthoma (KA) by histopathological features may not be sufficient for a differential diagnosis, as KAs may, in some cases, imitate well-differentiated SCCs.
📊
Temel Bulgular & Veri:Aims: In this study, we investigated whether the expression of the p16, p21, p27, p53 genes and a Ki-67 proliferation index are useful in distinguishing between these two tumors.
💡
Sonuç & Katkı:Results: The results of all of the examined markers, except for p27 (p16, p21, p53, and Ki-67) were found to be significantly different between the SCC and KA samples (p
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Abstract
Background: Distinguishing squamous cell carcinoma (SCC) from keratoacanthoma (KA) by histopathological features may not be sufficient for a differential diagnosis, as KAs may, in some cases, imitate well-differentiated SCCs. Aims: In this study, we investigated whether the expression of the p16, p21, p27, p53 genes and a Ki-67 proliferation index are useful in distinguishing between these two tumors. Study Design: Cross-sectional study. Methods: Immunohistochemistry was used to investigate the expression of the p16, p21, p27, p53 genes and the Ki-67 proliferation index was investigated in well-differentiated SCC with KA-like features (n=40) and KA (n=30). Results: The results of all of the examined markers, except for p27 (p16, p21, p53, and Ki-67) were found to be significantly different between the SCC and KA samples (p
🔖
Bu Makaleye Atıf Yap
BAĞCI, P., GÜÇER, H., ÜSTÜNER, P., BEDİR, R., ŞEHİTOĞLU, İ., YURDAKUL, C. (2022). The Role of p16, p21, p27, p53 and Ki-67 Expression in the Differential Diagnosis of Cutaneous Squamous Cell Carcinomas and Keratoacanthomas: An Immunohistochemical Study. Balkan Medical Journal, Cilt: 33 - Sayı: 2, 121–127. https://ajindex.com/articles/461313
Vasiljevic N, Andersson K, Bjelkenkrantz K, Kjellström C, Mansson H, Nilsson E, et al. The Bcl-xL inhibitor of apoptosis is preferentially expressed in cutaneous squamous cell carcino- ma compared with that in keratoacanthoma. Int J Cancer 2009; 124:2361-6. [CrossRef] Stern RS. The mysteries of geographic variability in nonmela- noma skin cancer incidence. Arch Dermatol 1999;135:843-4. [CrossRef] Schwartz RA. Keratoacanthoma. J Am Acad Dermatol 1994;30:1-19. [CrossRef] Ko CJ.Keratoacanthoma: facts and controversies. Clin Derma- tol 2010;28:254-61. [CrossRef] Kingman J, Callen JP. Keratoacanthoma. A clinical study. Arch Dermatol 1984;120:736-40. [CrossRef] Cain CT, Niemann TH, Argenyi ZB. Keratoacanthoma versus squa- mous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacan- thoma-like tumors. Am J Dermatopathol 1995;17:324-31.
Putti TC, Teh M, Lee YS. Biological behavior of keratoacantho- ma and squamous cell carcinoma: telomerase activity and COX- 2 as potential markers. Mod Pathol 2004;17:468-75. [CrossRef] Ho T, Horn T, Finzi E. Transforming growth factor alpha expres- sion helps to distinguish keratoacanthomas from squamous cell carcinomas. Arch Dermatol 1991;127:1167-71. [CrossRef] Takeda H, Kondo S. Differences between squamous cell carci- noma and keratoacanthoma in angiotensin type-1 receptor ex- pression. Am J Pathol 2001;158:1633-7. [CrossRef] Melendez ND, Smoller BR, Morgan M. VCAM (CD-106) and ICAM (CD-54) adhesion molecules distinguish keratoacantho- mas from cutaneous squamous cell carcinomas. Mod Pathol 2003;16:8-13. [CrossRef] Skalova A, Michal M. Patterns of cell proliferation in actinic keratoacanthomas and squamous cell carcinomas of the skin. Immunohistochemical study using the MIB 1 antibody in forma- lin-fixed paraffin sections. Am J Dermatopathol 1995;17:332-4.
Kaabipour E, Haupt HM, Stern JB, Kanetsky PA, Podolski VF, Martin AM. p16 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study. Arch Pathol Lab Med 2006;130:69-73.
Kuivanen TT, Jeskanen L, Kyllönen L, Impola U, Saarialho- Kere UK. Transformation-specific matrix metalloproteinases, MMP-7 and MMP-13, are present in epithelial cells of keratoac- anthomas. Mod Pathol 2006;19:1203-12. [CrossRef] Mukunyadzi P, Sanderson RD, Fan CY, Smoller BR. The level of syndecan-1 expression is a distinguishing feature in behav- ior between keratoacanthoma and invasive cu